重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 8 月 29 日 (二)股东大会召开的地点：山东省东营市垦利区同兴路 198 号石大胜华办公楼 A402 室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 证券代码：603026 证券简称：石大胜华 公告编号：2025-051 石大胜华新材料集团股份有限公司 2025年第三次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 1、出席会议的股东和代理人人数 | 311 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 81,974,354 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 35.2273 | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由公司董事会召集，由董事长郭天明先生主持，大会采取现场投票与网络投票 相结合的方式进行表决。本次会议 ...

ⳉ㔪䅃ボ㭊 致：石大胜华新材料集团股份有限公司 根据《中华人民共和国公司法》《中华人民共和国证券法》等相关法律、法 规和规范性文件及《石大胜华新材料集团股份有限公司章程》（以下简称"公司 章程"）的规定，北京市中伦律师事务所（以下简称"本所"）接受石大胜华新 材料集团股份有限公司（以下简称"公司"）委托，对公司 2025 年第三次临时 股东大会（以下简称"本次股东大会"）的相关事项进行见证并出具法律意见。 ⡒㈊㬱䐱㔸㔪㬇㬣㹒㰚 䇻㬐⫔㬅⿋㾣⤥㑰ゐ㵦⳾䇱㻿⹌㯟 2025 㛋⭻㧞⪯㑺㬒Ⰼ⫔。⭥ 为出具本法律意见书，本所律师审查了公司提供的相关文件，该等文件包括 但不限于： 1. 现行有效的公司章程； 2. 公司刊登在上海证券交易所（http://www.sse.com.cn/）的公司董事会关于 召开本次股东大会的通知； 3. 公司本次股东大会股权登记日的股东名册等资料； 4. 公司本次股东大会的相关会议文件。 本法律意见书仅供公司为本次股东大会之目的使用，本所律师同意将本法律 - 1 - 法律意见书 意见书随同公司本次股东大会决议及其他信息披露资料一并公告。 本所律师根据相关法律法规的要求，按照律师行业公认的业务 ...

Group 1 - Tianqi Materials reported a revenue of 7.03 billion yuan for the first half of 2025, a year-on-year increase of 28.97% [2][3] - The net profit attributable to shareholders was 268 million yuan, up 12.79% year-on-year, while the net profit excluding non-recurring items was 235 million yuan, reflecting a growth of 26.01% [2][3] - Basic earnings per share increased to 0.14 yuan, a rise of 16.67% compared to the previous year [3] Group 2 - New Zobang achieved a revenue of 4.25 billion yuan, marking an 18.58% increase year-on-year, with a net profit of 484 million yuan, up 16.36% [5][6] - The net profit excluding non-recurring items was 466 million yuan, showing an 8.16% increase [5][6] - Basic earnings per share rose to 0.64 yuan, a 16.36% increase from the previous year [6] Group 3 - Ruida New Materials reported a revenue of 975 million yuan, a decline of 7.36% year-on-year, with a net profit of 82 million yuan, down 24.19% [7][8] - The net profit excluding non-recurring items was 79 million yuan, reflecting a decrease of 27.57% [7][8] - The company experienced a negative cash flow from operating activities of 80 million yuan [8] Group 4 - Yongtai Technology reported a revenue of 2.61 billion yuan, a year-on-year increase of 21.97%, with a net profit of 59 million yuan, up 56.17% [10][11] - The net profit excluding non-recurring items was 23 million yuan, down 15.08% [10][11] - Basic earnings per share increased to 0.06 yuan, a 50% rise compared to the previous year [11] Group 5 - Shida Shenghua reported a revenue of 3.01 billion yuan, a year-on-year increase of 14.87%, but a net loss of 56 million yuan, a decline of 248.03% [13][14] - The net loss excluding non-recurring items was 57 million yuan, down 282.11% [13][14] - The company reported a positive cash flow from operating activities of 90 million yuan [14] Group 6 - Duofluor reported a revenue of 4.33 billion yuan, a decline of 6.65% year-on-year, with a net profit of 51 million yuan, down 16.55% [15][16] - The net profit excluding non-recurring items was a loss of 4.81 million yuan, reflecting a decrease of 179.71% [15][16] - Basic earnings per share decreased to 0.0441 yuan, down 15.19% [16] Group 7 - Tianji Co. reported a revenue of 1.07 billion yuan, a year-on-year increase of 19.16%, but a net loss of 52 million yuan, an improvement of 59% compared to the previous year [18][19] - The net loss excluding non-recurring items was 56 million yuan, down 56.04% [18][19] - The company reported a negative cash flow from operating activities of 131 million yuan [19] Group 8 - Huayu Pharmaceutical reported a revenue of 882 million yuan, a decline of 1.73% year-on-year, with a net loss of 5.81 million yuan, a decline of 116.23% [21][22] - The net loss excluding non-recurring items was 21.59 million yuan, down 247.06% [21][22] - The company reported a negative cash flow from operating activities of 169 million yuan [22] Group 9 - Haike New Source reported a revenue of 2.32 billion yuan, a year-on-year increase of 27.92%, but a net loss of 42 million yuan, an improvement of 61.21% [23][24] - The net loss excluding non-recurring items was 49 million yuan, down 56.57% [23][24] - The company reported a negative cash flow from operating activities of 248 million yuan [24] Group 10 - Hualu Hengsheng reported a revenue of 15.76 billion yuan, a decline of 7.14% year-on-year, with a net profit of 1.57 billion yuan, down 29.47% [26][27] - The net profit excluding non-recurring items was 1.56 billion yuan, reflecting a decrease of 30.29% [26][27] - Basic earnings per share decreased to 0.739 yuan, down 29.48% [27] Group 11 - Huasheng Lithium reported a revenue of 349 million yuan, a year-on-year increase of 72.02%, but a net loss of 72 million yuan [29] - The net profit excluding non-recurring items was a loss of 78 million yuan [29] - The company reported a negative cash flow from operating activities of 183 million yuan [29] Group 12 - Fuxiang Pharmaceutical reported a revenue of 514 million yuan, a decline of 24.58% year-on-year, with a net loss of 6.91 million yuan, an increase of 69.23% [31][32] - The net loss excluding non-recurring items was 32 million yuan, reflecting a decrease of 34.91% [31][32] - The company reported a negative cash flow from operating activities of 10 million yuan [32] Group 13 - Furui Co. reported a revenue of 2.59 billion yuan, a decline of 3.03% year-on-year, but a net profit of 246 million yuan, an increase of 10.92% [34][35] - The net profit excluding non-recurring items was 250 million yuan, reflecting a growth of 15.71% [34][35] - The company reported a positive cash flow from operating activities of 447 million yuan [35] Group 14 - The overall performance of companies in the electrolyte and raw material sector has been poor, with most companies reporting unsatisfactory financial results [36] - Except for Tianqi and New Zobang, other companies in the electrolyte sector have shown average performance [36] - Companies in the lithium hexafluorophosphate sector have reported significant losses, with net profits declining across the board [36]

Group 1 - The core viewpoint of the news highlights the trading performance and financial metrics of Shida Shenghua, indicating a slight decline in stock price and a low level of financing and margin trading activity [1] - As of August 28, Shida Shenghua's financing balance is 320 million yuan, accounting for 4.26% of its market capitalization, which is below the 20th percentile level over the past year, indicating a low financing level [1] - The company reported a net financing purchase of 4.87 million yuan on August 28, with a total financing and margin trading balance of 322 million yuan [1] Group 2 - As of June 30, the number of shareholders for Shida Shenghua decreased by 6.92% to 37,300, while the average circulating shares per person increased by 7.43% to 5,437 shares [2] - For the first half of 2025, Shida Shenghua achieved operating revenue of 3.011 billion yuan, representing a year-on-year growth of 14.87%, but reported a net profit attributable to shareholders of -56.34 million yuan, a significant decrease of 248.03% [2] - Since its A-share listing, Shida Shenghua has distributed a total of 636 million yuan in dividends, with 68.91 million yuan distributed over the past three years [2]

Core Viewpoint - Shida Shenghua New Materials Group Co., Ltd. has established a comprehensive industrial layout over 23 years, focusing on carbonate products and expanding its production and sales networks both domestically and internationally [3][4]. Group 1: Company Development - The company began its journey in 2002 with the construction of its first dimethyl carbonate facility and has since developed five types of carbonate solvents, becoming the world's first manufacturer to offer all five [3]. - In 2016, the company expanded into lithium hexafluorophosphate products, followed by electrolyte additives and electrolytes in 2021, and silicon-based anode products in 2022 [3]. - In 2023, the company's electrolyte products were integrated into the supply chain of CATL (Contemporary Amperex Technology Co., Limited), marking a strategic shift to a one-stop procurement service provider for electrolyte materials [3]. Group 2: Production and Sales Network - The company has established production bases in various Chinese cities, including Jining, Quanzhou, Wuhan, and Meishan, and has set up subsidiaries in Japan, Europe, and the United States, along with an office in South Korea, creating a global sales network [3]. - The company utilizes both PO and EO production routes for carbonates, achieving an integrated industrial chain layout at its Dongying base, which maximizes economic profits through upstream and downstream product interconnections [3]. Group 3: Competitive Position - After 23 years of development, the company has built a diversified core product portfolio, a nationwide production base, a global sales network, a multi-tiered high-end customer base, and various production processes, maintaining industry leadership in market share, product quality, and overall competitiveness [4].

Core Viewpoint - The financial performance of Shida Shenghua (603026) for the first half of 2025 shows a significant increase in revenue but a drastic decline in net profit, indicating potential operational challenges and financial strain [1]. Financial Performance Summary - Total revenue for the first half of 2025 reached 3.011 billion yuan, a year-on-year increase of 14.87% compared to 2.621 billion yuan in 2024 [1]. - The net profit attributable to shareholders for the first half of 2025 was -56.34 million yuan, a decline of 248.03% from a profit of 38.06 million yuan in 2024 [1]. - The gross margin decreased to 4.76%, down 26.6% from 6.48% in the previous year [1]. - The net margin fell to -3.38%, a significant drop of 1688.04% from -0.19% in 2024 [1]. - Total accounts receivable increased by 106.52%, rising from 779 million yuan to 1.608 billion yuan [1]. Cash Flow and Financial Metrics - The net cash flow from operating activities increased by 115.24%, attributed to improved collections from customers and increased cash flow [2]. - Cash and cash equivalents decreased by 28.60%, from 1.241 billion yuan to 886 million yuan [1]. - The company’s financial expenses surged by 944.57%, primarily due to increased interest costs [4]. Investment and Debt Analysis - The net cash flow from investing activities increased by 221.04%, due to reduced cash payments for fixed and long-term asset acquisitions [4]. - The company’s debt situation is concerning, with interest-bearing debt rising by 3.95% to 2.706 billion yuan [1]. - The ratio of cash to current liabilities is only 37.23%, indicating potential liquidity issues [4]. Operational Insights - The company’s business model relies heavily on R&D, marketing, and capital expenditures, necessitating careful evaluation of capital projects and their financial viability [4]. - The historical return on invested capital (ROIC) has been relatively low, with a median of 10.91% since its listing, and a particularly poor ROIC of -1.29% in 2023 [4]. - The accounts receivable to profit ratio has reached an alarming 9794.54%, highlighting potential collection issues [4].

Group 1 - The company has signed a tripartite supervision agreement for the storage of raised funds to ensure proper management and protect investor rights [4][28][29] - The total amount of funds raised through the issuance of shares to specific targets is capped at 1,000,000,000.00 yuan, with a net amount of 982,169,508.71 yuan after deducting issuance costs [3][17][26] - The funds will be allocated to various projects, including a 22,000 tons/year lithium battery material production project, a 10,000 tons/year liquid lithium salt project, and a 1,100 tons/year additive project [27][29][30] Group 2 - The company will provide loans to its subsidiaries using the raised funds, with specific amounts allocated for each project [25][27][30] - The interest rates for the loans will be based on the company's average financing costs and relevant regulations [27][30][50] - The board of directors and the supervisory board have approved the adjustments to the investment amounts for the projects, ensuring compliance with relevant regulations [19][20][48][49]

证券代码：603026 证券简称：石大胜华 公告编号：临 2025-050 石大胜华新材料集团股份有限公司 第八届监事会第十三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 表决情况： 3 票赞成， 0 票弃权， 0 票反对。 （二）通过《关于使用募集资金向子公司提供借款以实施募投项目的议案》。 一、监事会会议召开情况 （一）本次监事会会议的召开符合有关法律、行政法规、部门规章、规范性 文件和公司章程的规定。 （二）本次监事会会议于 2025 年 8 月 25 日以邮件、电话方式向公司监事会 全体监事发出第八届监事会第十三次会议通知和材料。 （三）本次监事会会议于 2025 年 8 月 26 日以通讯表决方式在山东省东营市 垦利区同兴路 198 号石大胜华办公楼 A326 室召开。 （四）本次监事会应出席的监事 3 人，实际参与表决的监事 3 人。 （五）本次监事会会议由监事会主席高建宏先生主持。 二、监事会会议审议情况 （一）通过《关于调整募投项目募集资金投资额的议案》。 监事会认为，公司本次调整募投项 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 证券代码：603026 证券简称：石大胜华 公告编号：临 2025-049 石大胜华新材料集团股份有限公司 第八届董事会第二十一次会议决议公告 （一）本次董事会会议的召开符合有关法律、行政法规、部门规章、规范性 文件和公司章程的规定。 （二）本次董事会会议于 2025 年 8 月 25 日以邮件、电话方式向公司董事会 全体董事发出第八届董事会第二十一次会议通知和材料。 （三）本次董事会会议于 2025 年 8 月 26 日以现场加通讯表决方式在山东省 东营市垦利区同兴路 198 号石大胜华办公楼 A325 室召开。 （四）本次董事会应出席的董事 9 人，实际参与表决的董事 9 人。 （五）本次董事会会议由董事长郭天明先生主持。 二、董事会会议审议情况 （一）通过《关于调整募投项目募集资金投资额的议案》。 由于公司本次发行募集资金扣减发行费用后的实际募集资金净额略低于《关 于调整公司 2022 年度向特定对象发行 A 股股票方案的议案》调整后募投项目 ...

申万宏源证券承销保荐有限责任公司 关于石大胜华新材料集团股份有限公司 使用募集资金向子公司提供借款以实施募投项目的核查意见 申万宏源证券承销保荐有限责任公司（以下简称"保荐人"）作为石大胜华 新材料集团股份有限公司（以下简称"石大胜华"或"公司"）向特定对象发行 股票的保荐人，根据《上海证券交易所股票上市规则》《上海证券交易所上市公 司自律监管指引第 1 号——规范运作》《上海证券交易所上市公司自律监管指引 第 11 号——持续督导》等有关规定，对石大胜华使用募集资金向子公司提供借款 以实施募投项目的事项进行了核查，核查情况如下： 一、本次募集资金的基本情况 公司于 2024 年 9 月收到中国证券监督管理委员会（以下简称"中国证监会"） 出具的《关于同意石大胜华新材料集团股份有限公司向特定对象发行股票注册的 批复》（证监许可[2024]1288 号），同意公司 2022 年度向特定对象发行股票的注 册申请，根据《胜华新材 2022 年度向特定对象发行 A 股股票预案(三次修订稿)》， 本次向特定对象发行的股票数量不超过本次向特定对象发行前公司总股本的 30%， 即不超过 60,804,000.00 股（含本 ...